We are live on ! Find out more
PMSA

Patrick M. Sweeney & Associates Portfolio holdings

AUM $156M
1-Year Est. Return 19.16%
This Fund
S&P 500
This Quarter Est. Return
+6.44%
1 Year Est. Return
+19.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$145M
AUM Growth
+$11.5M
Cap. Flow
+$3.12M
Cap. Flow %
2.15%
Top 10 Hldgs %
37.25%
Holding
157
New
10
Increased
93
Reduced
31
Closed
1

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$492K
2
BP icon
BP
BP
+$214K
3
VO icon
Vanguard Mid-Cap ETF
VO
+$213K
4
A icon
Agilent Technologies
A
+$205K
5
O icon
Realty Income
O
+$199K

Top Sells

Rank Stock Value
1
HLN icon
Haleon
HLN
+$316K
2
KMB icon
Kimberly-Clark
KMB
+$202K
3
NVO
Novo Nordisk
NVO
+$116K
4
BX icon
Blackstone
BX
+$104K
5
CVS icon
CVS Health
CVS
+$35.7K

Sector Composition

Rank Sector Weight
1 Healthcare 23.43%
2 Financials 19.74%
3 Technology 14.74%
4 Industrials 14.49%
5 Consumer Staples 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABT icon
1
Abbott
ABT
$180B
$9.99M 6.87%
74,334
-75
-0.1% -$9.89K
AAPL icon
2
Apple
AAPL
$4.89T
$7.96M 5.48%
37,273
-88
-0.2% -$17.8K
JPM icon
3
JPMorgan Chase
JPM
$939B
$7.08M 4.87%
23,917
-12
-0.1% -$3.06K
BAC icon
4
Bank of America
BAC
$435B
$6.18M 4.25%
126,360
+714
+0.6% +$30K
MSFT icon
5
Microsoft
MSFT
$2.84T
$5.21M 3.59%
10,451
+77
+0.7% +$33.4K
ABBV icon
6
AbbVie
ABBV
$458B
$5.01M 3.45%
26,485
+1
+0% +$186
MRK icon
7
Merck
MRK
$324B
$3.89M 2.68%
48,119
+427
+0.9% +$33.9K
PFE icon
8
Pfizer
PFE
$140B
$3.45M 2.37%
135,932
+21,114
+18% +$492K
AMZN icon
9
Amazon
AMZN
$2.5T
$2.71M 1.87%
12,151
+243
+2% +$48.1K
GOOG icon
10
Alphabet (Google) Class C
GOOG
$3.9T
$2.66M 1.83%
14,709
+131
+0.9% +$21.6K
COST icon
11
Costco
COST
$415B
$2.56M 1.76%
2,593
+30
+1% +$29.8K
V icon
12
Visa
V
$677B
$2.53M 1.74%
7,048
+33
+0.5% +$11.5K
CVS icon
13
CVS Health
CVS
$137B
$2.35M 1.61%
34,793
-545
-2% -$35.7K
LLY icon
14
Eli Lilly
LLY
$1.07T
$2.31M 1.59%
2,957
-29
-1% -$22.5K
QQQ icon
15
Invesco QQQ Trust
QQQ
$450B
$2.18M 1.5%
3,917
-14
-0.4% -$6.96K
WM icon
16
Waste Management
WM
$95.9B
$2.09M 1.44%
9,216
-12
-0.1% -$2.78K
BX icon
17
Blackstone
BX
$104B
$1.99M 1.37%
12,856
-754
-6% -$104K
BRK.B icon
18
Berkshire Hathaway Class B
BRK.B
$1.07T
$1.69M 1.17%
3,492
CAT icon
19
Caterpillar
CAT
$409B
$1.51M 1.04%
3,789
+50
+1% +$16.7K
JNJ icon
20
Johnson & Johnson
JNJ
$635B
$1.43M 0.98%
9,146
+102
+1% +$15.7K
AVGO icon
21
Broadcom
AVGO
$1.82T
$1.34M 0.92%
4,866
+196
+4% +$42.6K
HD icon
22
Home Depot
HD
$332B
$1.32M 0.91%
3,559
+33
+0.9% +$11.9K
UNP icon
23
Union Pacific
UNP
$183B
$1.27M 0.88%
5,392
+45
+0.8% +$9.99K
ETN icon
24
Eaton
ETN
$157B
$1.27M 0.87%
3,497
+20
+0.6% +$6.16K
SPY icon
25
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$1.23M 0.84%
1,963
-12
-0.6% -$6.86K

Similar funds

Patrick M. Sweeney & Associates's Q2 2025 Portfolio in Review

As of Q2 2025, Patrick M. Sweeney & Associates held 157 positions worth $145M, up 8.6% from $134M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Patrick M. Sweeney & Associates's Q2 2025 filing shows 10 new, 93 increased, 31 reduced and 1 closed positions. Its largest new stake was BP: 7,301 shares worth $226K. The largest sale was Haleon, an estimated $316K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 26% a quarter earlier, followed by Financials and Technology.

  • Patrick M. Sweeney & Associates's largest Q2 2025 buy was BP: 7,301 shares worth $226K.
  • Patrick M. Sweeney & Associates added most to Pfizer in Q2 2025, an estimated $492K increase.
  • Patrick M. Sweeney & Associates's biggest Q2 2025 reduction was Haleon, cutting an estimated $316K.
  • Patrick M. Sweeney & Associates fully exited Kimberly-Clark in Q2 2025, selling an estimated $202K.
  • Patrick M. Sweeney & Associates's ten largest holdings make up 37% of its $145M portfolio in Q2 2025.
  • Patrick M. Sweeney & Associates opened 10 new positions and closed 1 in Q2 2025.
  • Patrick M. Sweeney & Associates's portfolio value rose 8.6% quarter-over-quarter to $145M.

Based on Patrick M. Sweeney & Associates's 13F filing for Q2 2025, filed 13 Aug 2025.